Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33733 Results Found
HHS: Laboratory developed tests do not require FDA approval or authorization
In an effort to reduce regulatory burden, the Food and Drug Administration will not require developers to submit a premarket approval application, premarket notification or emergency use authorization for laboratory developed tests, the Department of Health and Human Services announced this week.
HRSA awards $35M in grants to support rural hospitals, health care
The Health Resources and Services Administration awarded $35 million in grants to support rural hospitals and health care.
CMS extends deadline to apply for area wage index reclassification
Due to the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services extended the Sept. 1 deadline for hospitals to apply for reclassification of their Medicare area wage index for fiscal year 2022 until 15 days after the agency releases its inpatient prospective payment system final rule for FY 2021.
AHA expresses ‘profound concern’ about drug companies’ actions to undermine 340B program
The AHA sent letters to the heads of U.S. operations for five large drug companies — Merck, Eli Lilly, Sanofi, Novartis and AstraZeneca — expressing “profound concern” over actions they are taking to limit the distribution of certain 340B drugs to hospitals and health systems and asking them to “cease this conduct immediately.”
Advancing Racial Equity through Public Health Approaches to Community Violence August 19
Advancing Racial Equity through Public Health Approaches to Community Violence
HC3 Analyst Note TLP WHite: Thales Modules Vulnerability (CVE-2020-15858)
Researchers recently revealed an information about a vulnerability affecting the electronic chips that enable mobile communication in millions of internet connected devices.
Rural Health Services Special Edition Data Report HHS COVID-19, August 12, 2020
Thank you for your continued heroic work to care for your communities as our nation battles the COVID-19 pandemic.
Perspective: Recharging Our Caregivers for the Best Patient Care
August is traditionally the time to take a break, go on vacation, or just slow it down and relax for a bit. For many people, that’s off the table this year. COVID-19’s impact on health, our economy and our ability to gather in groups has been a game changer for people’s personal plans.
AHA expresses “profound concern” about drug companies’ actions to undermine 340B drug discount program
For more than 25 years, the 340B program has enabled hospitals that care for many low-income and uninsured patients to purchase certain outpatient drugs from drug companies at discounted prices